DLD Asset Management’s Soleno Therapeutics SLNO Stock Holding History

DLD Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$196K	–	451
2025 Q4	$232K	Buy	+5,000	New	+$274K	0.02%	267

DLD Asset Management's SLNO Position: Q1 2026 in Review

DLD Asset Management sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 5,000 shares — an estimated $196K sold.

DLD Asset Management first reported a position in SLNO in Q4 2025 and held it in 1 quarter. The position peaked at $232K in Q4 2025. 226 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

DLD Asset Management reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
DLD Asset Management sold 5,000 Soleno Therapeutics shares in Q1 2026, an estimated $196K.
DLD Asset Management first reported a position in Soleno Therapeutics in Q4 2025 and held it in 1 quarter.
DLD Asset Management's Soleno Therapeutics position peaked at $232K in Q4 2025.
226 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on DLD Asset Management's 13F filing for Q1 2026, filed 13 May 2026.